51 results
8-K
SLNO
Soleno Therapeutics Inc
16 Aug 23
Departure of Directors or Certain Officers
9:00am
, and company management teams on investment thesis assessment, capitalization strategy, mergers and acquisitions, clinical execution, and commercialization from
8-K
EX-99.1
5x9vz
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
10-Q
32q3sx
18 Dec 14
Quarterly report
12:00am
424B3
c3ek3
14 Oct 15
Prospectus supplement
12:00am
424B5
tjb 0ih83vq
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
9fa 3pdigvek3y
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
hvv19c
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
u2zsrsqc
22 Oct 19
Prospectus supplement for primary offering
4:24pm